LTI-03

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Rein Therapeutics

Overview

LTI-03 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.

LTI-03 clinical trials

NCT06968845 (Phase 2)NCT05954988 (Phase 1)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about LTI-03 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.